Melbourne Senate Public Hearing: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

On Monday, April 29, 2013 I’m appearing before a  Senate committee to give evidence about this bill put up by Greens Senator Richard Di Natale.

The committee is looking at the need for regulation of pharmaceutical industry conduct with regards to interactions with the medical profession and the appropriateness of the provisions in the bill that place restrictions on these interactions.

The “The Global Mail” has provided a timely analysis of Big Pharma’s spending on “educational meetings” to Australian health professionals, “A Million Dollars A Week“. See also, “U.S. sues Novartis over kickbacks“.

Meanwhile, the Australian government and/or DoHA still believe in industry self-regulation (and presumably fairies in the bottom of the garden as well).

linkedinrsslinkedinrssby feather

About Dr Ken Harvey

Public Health Physician, Medical activitist
This entry was posted in Pharmaceutical Promotion, Senate and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.